Development of a vaccine for the COVID-19-causing virus could be sped up by conducting controlled human infection studies, but the ethics need to be addressed first
Researchers from DTU have revealed the structure of an enzyme that can convert low-cost sugars into hard-to-produce alpha-GalNAc sugars with therapeutic properties